Dr. Delannoy studied biology at the Ecole Normale Superieure de Paris (1996-2000) and obtained his Ph.D. in plant physiology from the Montpellier University in 2003.

After post-doctoral positions in France and at the Plant Energy Biology Center (Perth, Australia), he currently holds a position of INRA researcher at the IPS2 (Orsay, France). He is also scientific advisor of the IPS2 transcriptomic platform. His publications include works on plant physiology, transcriptomics, genomics and statistical analysis of RNA-seq.

Dr. Alcalde studied Biology at the Universidad Complutense de Madrid, Spain (1988-1993) and in 1994, he obtained an M.Sc in Plant Physiology. In 1999, he completed his PhD in Biochemistry and Molecular Biology at the Institute of Catalysis (ICP-CSIC, Madrid).

From 2001 to 2003, Dr. Alcalde took up a postdoctoral position at CALTECH. After his return to ICP-Madrid, he was appointed as Staff Scientist of the CSIC and promoted to CSIC Researcher in 2014. Dr.

Alcalde has participated in several consecutive European Projects and research contracts with industries. Dr. Alcalde is co-author of several patents and over 70-SCI papers.

Dr. Gjumrakch Aliev, MD, PhD, President “GALLY” International Biomedical Research Institute Inc., San Antonio, Texas, USA. He also hold appointment with the University of Atlanta, as a Professor and as a Leading Scientist , Institute of Physiologically Active Compounds. Russian Academy of Sciences.

He received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1988 with cum laude. He authored and coauthored more than 500 publications in the fields of neurodegenerative diseases research (Alzheimer disease), as well as cardio- and cerebrovascular disease, cancer, and electron microscopy.

Prof. Antonelli is currently Director of the Immuno-Endocrine Section of Internal Medicine and Associate Professor in the Department of Clinical and Experimental Medicine, University of Pisa, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy. He graduated in Medicine cum laude at the University of Pisa in 1982, where he received the post-graduate Specialization in Endocrinology in 1985 and in Occupational Health in 1987. He received also the postgraduate Specialization in Oncology (at the University La Sapienza, Rome, Italy) in 1992. His researches have been published in more than 260 articles on International journals (Impact Factor >970; H index 54).

Dr. Barberis received a Ph.D. in Industrial Biotechnology from the University of Milano-Bicocca, Milan. Dr. Barberis also holds a Master in Bioinformatics from the University of Turin, Italy. After postdocs at the Max Planck Institute for Molecular Genetics and the Humboldt University in Berlin, currently Dr. Barberis is Assistant Professor at the Department of Synthetic Systems Biology, University of Amsterdam. Dr. Barberis research integrates experimental and computational approaches to identify design principles underlying cellular organization.

Dr. Barberis is Executive Director of the International Society of Systems Biology, ISSB, and Editor-in-Chief of In Silico Biology (IOS Press), journal of biological systems modeling and multi-scale simulation. Dr. Barberis is also Associate Editor of Frontiers in Systems Biology, and Board Member of npj Systems Biology and Applications (NPG), Current Opinion in Systems Biology (Elsevier) and Current Genomics (Bentham Science). .

Dr. Sebastiano Cavallaro received a medical degree and specialized in Neurology at the University of Catania (Italy). He also obtained a Ph.D. in Anatomy and Cell Biology at Georgetown University. He then worked at the NINDS-NIH (USA) and at the Blanchette Rockefeller Neurosciences Institute. Since 1997, Dr. Cavallaro works at the Italian National Research Council (CNR) and today directs the Institute of Neurological Sciences, a research center where clinical services and research activities thrive together. His primary research interests include genomics and neurobiology. During his career he supervised and supported the activity of more than 60 students or post-docs, authoring more than 100 publications.

Prof. Coppedè holds a degree in Biological Sciences and a Ph.D. in Microbiology and Genetics, both from the University of Pisa. He worked as visiting or postdoctoral researcher at the University of California Berkeley, King’s College London, and the Karolinska Institutet.

Currently, he is an Associate Professor of Medical Genetics at the Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa. His research is focused on genetic and epigenetic factors in Down syndrome, cancer and neurodegeneration. Author of almost 80 peer reviewed articles, Prof. Coppedè serves in the editorial board of several scientific journals, including Current Genomics.

Josée Dostie received her Ph.D. (2000) from McGill University, Montréal, Canada, for work conducted on mRNA translation and nucleo-cytoplasmic transport under the supervision of Dr. Nahum Sonenberg. She then completed her first postdoctoral training (2000 to 2004) with Dr. Gideon Dreyfuss at the University of Pennsylvania where she studied the function of ribonucleoprotein complexes. She was a Postdoctoral Fellow (2004 to 2007) in the laboratory of Dr. Job Dekker at the University of Massachusetts when she trained in genome organization. She is now Associate Professor in the Biochemistry department at McGill, and an Associate member of the Goodman Cancer Center in Montréal. Her research interests include how non-coding RNAs and chromatin structure regulate gene expression in cancer and during development.

Professor Dr. Fumin Lei is at the Institute of Zoology (IOZ), Chinese Academy of Sciences (CAS) in Beijing, China. After M.Sc. Zoology at Shaanxi Normal University, Fumin Lei received his Ph.D. in ornithology at IOZ, CAS. He was a Post-doc at the University of Michigan, USA, and a visiting professor in the California Academy of Sciences and the University of Washington, USA. Since 2000, Dr. Fumin Lei is Professor at IOZ, CAS. His research interests include taxonomy and evolution; molecular phylogeny and phylogeography; geographical distribution, endemism and biodiversity conservation; adaptive evolution by comparative genomics; and molecular epidemiology of wildlife diseases (e.g. avian influenza).

Jörg Hoheisel heads the Division of Functional Genome Analysis at the German Cancer Research Center (DKFZ) in Heidelberg. His research objectives are the assessment and description of the realisation and regulation of cellular functions, with a particular focus on the analysis of protein variations and interactions by means of affinity proteomics. Another line of work is Synthetic Biology for the establishment of artificial molecular systems. Prior to joining DKFZ, Jörg worked for five years at the Imperial Cancer Research Fund in London, UK. Previously, he had studied molecular biology and completed his PhD at the University of Constance, Germany.

Ivan Y. Iourov heads the laboratory of molecular brain genetics at Mental Health Research Center, Moscow, Russia. His research is focused on biological basis of neuropsychiatric diseases, molecular genetics and bioinformatics. He is author/co-author of 4 books and 220 articles/book chapters. Prof Iourov is a founder of Molecular Cytogenetics, editor-in-chief of Journal of Neurology and Epidemiology, and editor of Current Genomics and Current Bioinformatics (regional editor). The results of his research were distinguished by a number of awards, among which SciVal/Scopus Award Russia 2012 (Elsevier prize), VM Bekhterev’s Prize for the highest scientific achievements in neurology and psychiatry, the Grant of the President of the Russian Federation and Blue Bird Award (Russian National Award for the achievements in helping people with rare diseases, improvement of the legislation, diagnosis, treatment and rehabilitation of patients with rare diseases, and scientific research in the field of rare diseases and orphan drugs).

Dr. Kone is a tenured professor and graduate faculty member at the University of Texas-Houston. He received his A.B. degree from Princeton University, his M.D. degree from University of Florida, and clinical training at Johns Hopkins Hospital and Harvard Medical School. He joined the University of Texas-Houston in 1995 and served as the chairman of internal medicine, then became Dean of the University of Florida College of Medicine, before returning to University of Texas-Houston. He has held multiple leadership, editorial board, and peer review. He investigates transcriptional control of epithelial transport, and has been NIH funded for 30 years.

Jianbing Mu M.D., Ph.D., is staff scientist at Laboratory of Malaria and Vector Research at National Institute of Allergy and Infectious Diseases, USA. Dr. Jianbing Mu received his PhD from Saitama Medical University in Japan. His research interest has been on the functional genomics of P. falciparum and its human host, including genetic mapping, genome-wide association (GWA) studies and epigenetic mechanisms of gene regulation.

Prof. Musarò obtained a doctorate (Ph.D.) in Biotechnological Sciences from Sapienza University of Rome and completed a 4-year post-doctoral term at Harvard University (USA). From 2003 to 2014 Prof. Musarò was Adjunct Associate Professor, School of Biomedical & Sports Science at the Edith Cowan University; Western Australia. Currently Prof. Musarò is an Associate Professor of Medicine and Biotechnology at Sapienza University of Rome, Italy. He has published more than 100 scientific publications.

Dr. Maurizio Onisto received his B.Sc and Ph.D. in Molecular and cellular biology and pathology from the University of Padova (Italy) followed by postdoctoral training as Visiting Fellow at National Cancer Institute (NIH) of Bethesda, MD, (USA). Since 1997, he coordinates a research group devoted to the study of extracellular matrix pathobiology. Currently Dr. Onisto is Associate Professor at School of Medicine of Padova University. His research is published in over 60 original papers and has been presented at leading international conferences. Nowadays he is Editorial Board Member of Current Genomics.

Prof. Pandey received Ph.D. from Jawaharlal Nehru University (JNU), India and pursed his post-doctoral research work at the Department of Plant and Microbial Biology, University of California at Berkeley. Currently, he is working as Professor in the Department of Plant Molecular Biology, Delhi University South Campus. His group’s research interest is to understand the detail mechanistic interplay of signal transduction networks in plants under mineral nutrient deficiency and abiotic stresses. He has published more than 60 scientific publications, edited 7 books/volumes and also has 2 US patents.

Dr. Edward Ratovitski obtained his Ph.D. Degree in Molecular Biology and Cancer Biology (1979) from the N.N. Petrov Cancer Research Institute (Leningrad, Soviet Union). Currently Dr. Ratovitski is an Adjunct Professor in the Head and Neck Cancer Research Division of the Johns Hopkins University School of Medicine (Baltimore, MD, USA) and the Department of Mechanical and Aerospace Engineering, George Washington University (DC, USA). He has published more than 136 scientific publications, and is a named inventor of five issued US patents.

Dr. Ratovitski is an Editorial Board Member of the Current Genomics (CG) journal published by Bentham Science Publishers.

Paula Soares, BSc, MSc, PhD, is Assistant Professor of Biopathology at the Medical Faculty of the University of Porto and coordinates the Group of Cancer Biology at the Institute of Pathology and Immunology of the University of Porto (Ipatimup) – Instituto de Investigação e Inovação em Sáude (i3S), Portugal. She received her degrees in Biology, Master in Oncobiology, and PhD in Human Biology at the University of Porto. Her main interests include oncobiology of thyroid and neuroendocrine tumours mainly addressing thyroid cancer genetic alterations and signal transduction molecules involved in the MAPK and mTOR pathways.

Dr. Zhongming Zhao is Dr. Doris L. Ross Professor and the founding director of Center for Precision Health, the University of Texas Health Science Center at Houston (UTHealth). Dr. Zhao received his master’s degrees in Genetics (1996), Biomathematics (1998), Computer Science (2002), Ph.D. degree in Human and Molecular Genetics (2000), and Postdoctoral Fellow in Bioinformatics (2001-2003). Dr. Zhao has more than 18 years of bioinformatics and systems biology research experience and published more than 260 papers in these areas. More details are available at https://www.uth.edu/bioinfo/.

Dr Tomasz Powrózek is a research associate at Department of Human Physiology; Medical University of Lublin, Poland. During his doctoral training, he developed new potential markers for early lung cancer detection based on analysis of epigenetics markers using liquid biopsy. Nowadays, he is active in investigation of novel molecular markers in blood circulation of head and neck cancer patients (detection, prediction and prognosis). The main area of interest concerns understanding the molecular background of malnutrition and cachexia in cancer patients. Dr Powrózek is an author of over 100 scientific reports as well as he reviewed over 100 papers.